Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Targeted Therapy
1.4.3 Radiation Therapy
1.4.4 Immunotherapy
1.4.5 Chemotherapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Liver Cancer Therapeutics Market Share by Application (2019-2025)
1.5.2 Hepatocellular Carcinoma
1.5.3 Cholangio Carcinoma
1.5.4 Hepatoblastoma
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Liver Cancer Therapeutics Market Size
2.2 Liver Cancer Therapeutics Growth Trends by Regions
2.2.1 Liver Cancer Therapeutics Market Size by Regions (2019-2025)
2.2.2 Liver Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Liver Cancer Therapeutics Market Size by by Players
3.1.1 Global Liver Cancer Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Liver Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Liver Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Liver Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Liver Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Liver Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Liver Cancer Therapeutics Market Size by Application (2014-2019)
5 North America
5.1 North America Liver Cancer Therapeutics Market Size (2014-2019)
5.2 Liver Cancer Therapeutics Key Players in North America
5.3 North America Liver Cancer Therapeutics Market Size by Type
5.4 North America Liver Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Liver Cancer Therapeutics Market Size (2014-2019)
6.2 Liver Cancer Therapeutics Key Players in Europe
6.3 Europe Liver Cancer Therapeutics Market Size by Type
6.4 Europe Liver Cancer Therapeutics Market Size by Application
7 China
7.1 China Liver Cancer Therapeutics Market Size (2014-2019)
7.2 Liver Cancer Therapeutics Key Players in China
7.3 China Liver Cancer Therapeutics Market Size by Type
7.4 China Liver Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Liver Cancer Therapeutics Market Size (2014-2019)
8.2 Liver Cancer Therapeutics Key Players in Japan
8.3 Japan Liver Cancer Therapeutics Market Size by Type
8.4 Japan Liver Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Liver Cancer Therapeutics Market Size (2014-2019)
9.2 Liver Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Liver Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Liver Cancer Therapeutics Market Size by Application
10 India
10.1 India Liver Cancer Therapeutics Market Size (2014-2019)
10.2 Liver Cancer Therapeutics Key Players in India
10.3 India Liver Cancer Therapeutics Market Size by Type
10.4 India Liver Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Liver Cancer Therapeutics Market Size (2014-2019)
11.2 Liver Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Liver Cancer Therapeutics Market Size by Type
11.4 Central & South America Liver Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 ArQule
12.1.1 ArQule Company Details
12.1.2 Company Description and Business Overview
12.1.3 Liver Cancer Therapeutics Introduction
12.1.4 ArQule Revenue in Liver Cancer Therapeutics Business (2014-2019))
12.1.5 ArQule Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Liver Cancer Therapeutics Introduction
12.2.4 Bayer Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Liver Cancer Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celsion
12.4.1 Celsion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Liver Cancer Therapeutics Introduction
12.4.4 Celsion Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.4.5 Celsion Recent Development
12.5 Eisai
12.5.1 Eisai Company Details
12.5.2 Company Description and Business Overview
12.5.3 Liver Cancer Therapeutics Introduction
12.5.4 Eisai Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.5.5 Eisai Recent Development
12.6 Exelixis
12.6.1 Exelixis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Liver Cancer Therapeutics Introduction
12.6.4 Exelixis Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.6.5 Exelixis Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Liver Cancer Therapeutics Introduction
12.7.4 Roche Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Liver Cancer Therapeutics Introduction
12.8.4 Merck Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Liver Cancer Therapeutics Introduction
12.9.4 Pfizer Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 IntegraGen
12.10.1 IntegraGen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Liver Cancer Therapeutics Introduction
12.10.4 IntegraGen Revenue in Liver Cancer Therapeutics Business (2014-2019)
12.10.5 IntegraGen Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
ArQule、Bayer、Bristol-Myers Squibb、Celsion、Eisai、Exelixis、Roche、Merck、Pfizer、IntegraGen